Leucovorin and maximum tolerated dose toxicity of methotrexate in rats

Pediatric Hematology and Oncology

Volumn 17, Issue 8, 2000, Pages 651-658

  Fuskevåg, Ole Martin ^a   Kristiansen, Christel ^a   Lindal, Sigurd ^a   Aarbakke, Jarle ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Acute toxicity; Leucovorin; Methotrexate; Rat

Indexed keywords

CALCIUM ION; CHLORIDE ION; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; POTASSIUM ION; SODIUM ION;

ACUTE LYMPHOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG MECHANISM; DRUG MEGADOSE; ENDOTHELIUM CELL; HEART RATE; MALE; MAXIMUM PERMISSIBLE DOSE; NONHUMAN; RAT; SURVIVAL TIME; TOXICITY TESTING;

EID: 0033661477     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010050211358     Document Type: Article

References (22)

1. Ode to methotrexate
2. Making TDM work to optimize cancer chemotherapy: A multidiciplinary team approach
3. Fifty years of studies of the biology and therapy of childhood leukemia
4. Methotrexate pharmacokinetics and prognosis in osteosarcoma
5. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effect of preoperative chemotherapy with single-agent high-dose methotrexate: A Scandinavian Sarcoma Group study
6. Acute lymphoblastic leukemia
7. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group phase III trial
8. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy: A Pediatric Oncology Group study
9. Oral versus intravenous methotrexate: Another opinion
10. 2 to children with acute lymphoblastic leukemia
11. Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy
12. High-dose 7-hydromethotrexate: Acute toxicity and lethality in a rat model
13. Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate after 8 h infusions in rats
14. Microvascular perturbations in rats receiving maximum tolerated dose of methotrexate or its major metabolite 7-hydroxymethotrexate
15. Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat
16. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration
17. Mechanism of leucovorin reversal of methotrexate cytotoxicity in human MCF-7 breast cancer cells
18. Methotrexate in rheumatoid arthritis: An update with focus on mechanisms involved in toxicity
19. Differential effects of the antifolates methotrexate, aminopterin and trimetrexate on routine haemopoietic progenitor cells
20. Effect of folinic acid on tissue residence and excretion of methotrexate in rats
21. Acute hepatotoxicity after high-dose methotrexate administration to rats
22. Ion regulation disorders and cardiac arrhythmia: The relevance of sodium, potassium, calcium, and magnesium